MIAMI, FL, UNITED STATES, December 30, 2025 /EINPresswire.com/ — AIdMD Technologies is pleased to announce the U.S. market launch of its artificial intelligence–powered healthcare platform, ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Primary sclerosing cholangitis (PSC) is a chronic, progressive inflammatory disease characterized by fibrosis and bile duct ...

Designed to empower users to understand the causes of their headaches, the app now includes a suite of tools to log symptoms, analyze, track treatment efficacy We created this app to address a very ...

Tools that health systems retired in 2025 reveal challenges in AI adoption, highlighting the need for oversight and workflow alignment.

India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...

The letter noted the FDA is unable to approve the application for ONS-5010/LYTENAVA (bevacizumab-vikg) in its current form ...

Discover how 2025 has reshaped India's healthcare landscape with key advancements in AI, policy changes, and investments, ...

In looking to 2026, the main trend in healthcare is how AI and connected systems will continue to transform all aspects of operations, including workforce management and supply chains. In a November ...

Live Science's health channel editor makes predictions about the medical breakthroughs and public health shifts to come in ...